Crinetics Pharmaceuticals Inc (CRNX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CRNX? Forum Prognose

Finanzdaten der Crinetics Pharmaceuticals Inc-Aktie (CRNX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4,208% 6.161	0.143	1.031	0.361	-
Operating Expenses	2.79% 138.75	142.73	130.14	111.77	87.80
Benefits Costs and Expenses	1.10% 128.80	130.23	-	-	-
Costs And Expenses	38.54% 180.43	130.23	130.14	111.77	87.80
Depreciation and Amortization	1.78% 0.994	1.012	0.959	0.925	0.77
Operating Income/Loss	6.26% -133.67	-142.59	-129.11	-111.41	-87.80
Nonoperating Income/Loss	11.72% 11.03	12.49	13.47	14.63	10.97
Income/Loss Before Equity Method Investments	5.73% -122.64	-130.09	-	-	-
Income/Loss From Equity Method Investments	-	-	-	-	-
Income/Loss From Continuing Operations Before Tax	5.73% -122.64	-130.09	1.031	0.361	-76.83
Income/Loss From Continuing Operations After Tax	5.59% -122.81	-130.09	-115.64	-96.77	-76.83
Net Income/Loss	5.59% -122.81	-130.09	-115.64	-96.77	-76.83
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.63% 0.35	94.22	93.79	93.10	80.09
Diluted Average Shares	99.63% 0.35	94.22	93.79	93.10	80.09
Basic Earnings Per Share	6.52% -1.29	-1.38	-1.23	-1.04	-0.96
Diluted Earnings Per Share	6.52% -1.29	-1.38	-1.23	-1.04	-0.96
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-